Rize ICAV Medical Cannabis & Life Sciences UCITS ETF GBP (FLWG)
20.40p
(3.56%)
- Add to watchlist
- Create an alert
- This stock can be held in a
20.40p
(3.56%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
20.40p
(3.56%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
578.40p
594.89p
815.80p
London
572.80p
567.38p
359.65p
$57.14M
19.60p (3.31%) Previous:
19.60p
27,833
n/a
GBX
ETP Basics
| Issuer: | Rize UCITS ICAV |
|---|---|
| Structure: | ETF |
| Replication method: | Stocks - Full Replication |
| Securities lending: | No |
| Number of holdings: | 32 |
| Size: | $57.1M |
| Launch date: | 12 February 2020 |
| Launch price: | $5.04 |
| UCITS: | Yes |
| Reporting status: | Yes |
| Domicile: | Ireland |
| Sophisticated product: | Non-sophisticated |
| ISIN: | IE00BJXRZ273 |
Annual & interim reports
Before you invest, please make sure you read the documents below
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
OBJECTIVE
| Index: | The Foxberry Medical Cannabis & Life Sciences Index provides exposure to companies involved in the global medical cannabis and cannabis-related life sciences sectors, with a focus on companies in the biotechnology/pharma and hemp and cannabidiol (CBD) sectors. The index excludes companies that are considered to be either non-compliant with state and federal laws in the countries in which they operate and/or directly involved in the production and/or distribution of cannabis and/or cannabis-derived products containing more than hemp-defined levels of tetrahydrocannabinol for the recreational consumer market. The index follows a modified liquidity-based weighting scheme where companies with higher liquidity achieve a bigger weight in the index |
|---|---|
| Aim: |
The Rize Medical Cannabis and Life Sciences UCITS ETF (FLWR) seeks to invest in...
Read full aim for Rize ICAV |
| Leverage: | 100% |
| Currency hedging: | No |
COSTS
| Ongoing Charge (OCF/TER): | 0.65% |
|---|---|
| Management fee: | 0.65% |
| Indicative spread: | 0.47% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
Not available for this stock.
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
| Security | Weight |
|---|---|
| SCOTTS MIRACLE-GRO CO | 16.93% |
| GROWGENERATION CORP | 15.89% |
| GW PHARMACEUTICALS | 15.00% |
| AMYRIS INC | 10.54% |
| ARENA PHARMACEUTICALS INC | 7.82% |
| CORBUS PHARMACEUTICALS HLDGS INC | 7.25% |
| ZYNERBA PHARMACEUTICALS INC | 5.93% |
| ABBVIE INC | 2.56% |
| TEVA PHARMACEUTICAL INDUSTRIES | 2.50% |
| INDIA GLOBALIZATION CAPITAL INC | 2.49% |
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.